These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28695243)

  • 1. CNS metabolism in high-risk drug abuse : Insights gained from
    Bodea S
    Radiologe; 2018 Nov; 58(Suppl 1):34-39. PubMed ID: 28695243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CNS metabolism in high-risk drug abuse, German version : Insights gained from
    Bodea SV
    Radiologe; 2017 Jun; 57(6):443-449. PubMed ID: 28516232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the heroin 'drought' on patterns of drug use and drug-related harms.
    Longo MC; Henry-Edwards SM; Humeniuk RE; Christie P; Ali RL
    Drug Alcohol Rev; 2004 Jun; 23(2):143-50. PubMed ID: 15370019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine use and the utilisation of drug help services by consumers of the open drug scene in Hamburg.
    Verthein U; Haasen C; Prinzleve M; Degkwitz P; Krausz M
    Eur Addict Res; 2001 Dec; 7(4):176-83. PubMed ID: 11752848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continued rise of methamphetamine use among people who use heroin in the United States.
    Strickland JC; Stoops WW; Dunn KE; Smith KE; Havens JR
    Drug Alcohol Depend; 2021 Aug; 225():108750. PubMed ID: 34052690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
    Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A
    Int J Drug Policy; 2023 Mar; 113():103976. PubMed ID: 36822010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.
    Meacham MC; Rudolph AE; Strathdee SA; Rusch ML; Brouwer KC; Patterson TL; Vera A; Rangel G; Roesch SC
    Subst Use Misuse; 2015; 50(10):1351-9. PubMed ID: 26444185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-drug and marijuana use among adults who primarily used methamphetamine.
    Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
    J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reports of consumption of amphetamines, cocaine and heroin in a survey among marginalized drug users.
    Amundsen EJ; Reid MJ
    Sci Total Environ; 2014 Jul; 487():740-5. PubMed ID: 24411996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in drugs-of-abuse in Los Angeles County].
    Moriya F
    Nihon Hoigaku Zasshi; 1994 Jun; 48(3):185-90. PubMed ID: 8065069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.
    Cunningham JK; Liu LM; Callaghan RC
    Addiction; 2016 Nov; 111(11):1999-2009. PubMed ID: 27529812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010-2015.
    Wilkins C; Prasad J; Parker K; Rychert M; Barnes HM
    Curr Top Behav Neurosci; 2017; 34():161-172. PubMed ID: 28434182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.
    Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P
    Addiction; 2015 Jan; 110(1):120-8. PubMed ID: 25220170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine's fall and marijuana's rise: questions and insights based on new estimates of consumption and expenditures in US drug markets.
    Caulkins JP; Kilmer B; Reuter PH; Midgette G
    Addiction; 2015 May; 110(5):728-36. PubMed ID: 25039446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lead of intravenous drug users.
    Norton RL; Burton BT; McGirr J
    J Toxicol Clin Toxicol; 1996; 34(4):425-30. PubMed ID: 8699557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.
    Jenkins AJ; Oyler JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):359-74. PubMed ID: 8926729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in illicit drug trafficking from the Canadian perspective.
    Stamler RT; Fahlman RC; Keele SA
    Bull Narc; 1983; 35(4):23-32. PubMed ID: 6563922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia.
    Roxburgh A; Degenhardt L; Breen C
    Drug Alcohol Rev; 2004 Sep; 23(3):287-94. PubMed ID: 15370008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric morbidity among cocaine and heroin users in the community.
    Tortajada S; Herrero MJ; Domingo-Salvany A; Molist G; Barrio G; de la Fuente L; Brugal MT;
    Adicciones; 2012; 24(3):201-10. PubMed ID: 22868975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.